GenericsWeb Analyses Generic Opportunities for Merck’s Blockbuster Ezetimibe

GenericsWeb, the leader in established pharmaceutical patent analysis and searching, recently published an article based on its proprietary Pipeline Patent Intelligence that analyses opportunities in launching generic versions of Merck’s cholesterol lowering medicines Ezetrol®/Zetia® (Ezetimibe) and Inegy®/Vytorin® (Ezetimibe/Simvastatin) with reported global sales in 2010 of USD $2.3bn and $2 …

Leave a Reply

Your email address will not be published.